Request for Covid-19 Impact Assessment of this Report
The United States Lubiprostone market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lubiprostone market, reaching US$ million by the year 2028. As for the Europe Lubiprostone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Lubiprostone players cover Takeda Pharmaceuticals, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Lubiprostone market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
8 mcg Capsules
24 mcg Capsules
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
CIC and OIC
IBS-C
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Takeda Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lubiprostone Market Size 2017-2028
2.1.2 Lubiprostone Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Lubiprostone Segment by Type
2.2.1 8 mcg Capsules
2.2.2 24 mcg Capsules
2.3 Lubiprostone Market Size by Type
2.3.1 Lubiprostone Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Lubiprostone Market Size Market Share by Type (2017-2022)
2.4 Lubiprostone Segment by Application
2.4.1 CIC and OIC
2.4.2 IBS-C
2.5 Lubiprostone Market Size by Application
2.5.1 Lubiprostone Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Lubiprostone Market Size Market Share by Application (2017-2022)
3 Lubiprostone Market Size by Player
3.1 Lubiprostone Market Size Market Share by Players
3.1.1 Global Lubiprostone Revenue by Players (2020-2022)
3.1.2 Global Lubiprostone Revenue Market Share by Players (2020-2022)
3.2 Global Lubiprostone Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lubiprostone by Regions
4.1 Lubiprostone Market Size by Regions (2017-2022)
4.2 Americas Lubiprostone Market Size Growth (2017-2022)
4.3 APAC Lubiprostone Market Size Growth (2017-2022)
4.4 Europe Lubiprostone Market Size Growth (2017-2022)
4.5 Middle East & Africa Lubiprostone Market Size Growth (2017-2022)
5 Americas
5.1 Americas Lubiprostone Market Size by Country (2017-2022)
5.2 Americas Lubiprostone Market Size by Type (2017-2022)
5.3 Americas Lubiprostone Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lubiprostone Market Size by Region (2017-2022)
6.2 APAC Lubiprostone Market Size by Type (2017-2022)
6.3 APAC Lubiprostone Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lubiprostone by Country (2017-2022)
7.2 Europe Lubiprostone Market Size by Type (2017-2022)
7.3 Europe Lubiprostone Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lubiprostone by Region (2017-2022)
8.2 Middle East & Africa Lubiprostone Market Size by Type (2017-2022)
8.3 Middle East & Africa Lubiprostone Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lubiprostone Market Forecast
10.1 Global Lubiprostone Forecast by Regions (2023-2028)
10.1.1 Global Lubiprostone Forecast by Regions (2023-2028)
10.1.2 Americas Lubiprostone Forecast
10.1.3 APAC Lubiprostone Forecast
10.1.4 Europe Lubiprostone Forecast
10.1.5 Middle East & Africa Lubiprostone Forecast
10.2 Americas Lubiprostone Forecast by Country (2023-2028)
10.2.1 United States Lubiprostone Market Forecast
10.2.2 Canada Lubiprostone Market Forecast
10.2.3 Mexico Lubiprostone Market Forecast
10.2.4 Brazil Lubiprostone Market Forecast
10.3 APAC Lubiprostone Forecast by Region (2023-2028)
10.3.1 China Lubiprostone Market Forecast
10.3.2 Japan Lubiprostone Market Forecast
10.3.3 Korea Lubiprostone Market Forecast
10.3.4 Southeast Asia Lubiprostone Market Forecast
10.3.5 India Lubiprostone Market Forecast
10.3.6 Australia Lubiprostone Market Forecast
10.4 Europe Lubiprostone Forecast by Country (2023-2028)
10.4.1 Germany Lubiprostone Market Forecast
10.4.2 France Lubiprostone Market Forecast
10.4.3 UK Lubiprostone Market Forecast
10.4.4 Italy Lubiprostone Market Forecast
10.4.5 Russia Lubiprostone Market Forecast
10.5 Middle East & Africa Lubiprostone Forecast by Region (2023-2028)
10.5.1 Egypt Lubiprostone Market Forecast
10.5.2 South Africa Lubiprostone Market Forecast
10.5.3 Israel Lubiprostone Market Forecast
10.5.4 Turkey Lubiprostone Market Forecast
10.5.5 GCC Countries Lubiprostone Market Forecast
10.6 Global Lubiprostone Forecast by Type (2023-2028)
10.7 Global Lubiprostone Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Takeda Pharmaceuticals
11.1.1 Takeda Pharmaceuticals Company Information
11.1.2 Takeda Pharmaceuticals Lubiprostone Product Offered
11.1.3 Takeda Pharmaceuticals Lubiprostone Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Takeda Pharmaceuticals Main Business Overview
11.1.5 Takeda Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Lubiprostone Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 8 mcg Capsules
Table 3. Major Players of 24 mcg Capsules
Table 4. Lubiprostone Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Lubiprostone Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Lubiprostone Market Size Market Share by Type (2017-2022)
Table 7. Lubiprostone Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Lubiprostone Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Lubiprostone Market Size Market Share by Application (2017-2022)
Table 10. Global Lubiprostone Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Lubiprostone Revenue Market Share by Player (2020-2022)
Table 12. Lubiprostone Key Players Head office and Products Offered
Table 13. Lubiprostone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Lubiprostone Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Lubiprostone Market Size Market Share by Regions (2017-2022)
Table 18. Americas Lubiprostone Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Lubiprostone Market Size Market Share by Country (2017-2022)
Table 20. Americas Lubiprostone Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Lubiprostone Market Size Market Share by Type (2017-2022)
Table 22. Americas Lubiprostone Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Lubiprostone Market Size Market Share by Application (2017-2022)
Table 24. APAC Lubiprostone Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Lubiprostone Market Size Market Share by Region (2017-2022)
Table 26. APAC Lubiprostone Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Lubiprostone Market Size Market Share by Type (2017-2022)
Table 28. APAC Lubiprostone Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Lubiprostone Market Size Market Share by Application (2017-2022)
Table 30. Europe Lubiprostone Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Lubiprostone Market Size Market Share by Country (2017-2022)
Table 32. Europe Lubiprostone Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Lubiprostone Market Size Market Share by Type (2017-2022)
Table 34. Europe Lubiprostone Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Lubiprostone Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Lubiprostone Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Lubiprostone Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Lubiprostone Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Lubiprostone Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Lubiprostone Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Lubiprostone Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Lubiprostone
Table 43. Key Market Challenges & Risks of Lubiprostone
Table 44. Key Industry Trends of Lubiprostone
Table 45. Global Lubiprostone Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Lubiprostone Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Lubiprostone Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Lubiprostone Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Lubiprostone Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Lubiprostone Market Size Market Share Forecast by Application (2023-2028)
Table 51. Takeda Pharmaceuticals Details, Company Type, Lubiprostone Area Served and Its Competitors
Table 52. Takeda Pharmaceuticals Lubiprostone Product Offered
Table 53. Takeda Pharmaceuticals Lubiprostone Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Takeda Pharmaceuticals Main Business
Table 55. Takeda Pharmaceuticals Latest Developments
List of Figures
Figure 1. Lubiprostone Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lubiprostone Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Lubiprostone Market Size Market Share by Type in 2021
Figure 7. Lubiprostone in CIC and OIC
Figure 8. Global Lubiprostone Market: CIC and OIC (2017-2022) & ($ Millions)
Figure 9. Lubiprostone in IBS-C
Figure 10. Global Lubiprostone Market: IBS-C (2017-2022) & ($ Millions)
Figure 11. Global Lubiprostone Market Size Market Share by Application in 2021
Figure 12. Global Lubiprostone Revenue Market Share by Player in 2021
Figure 13. Global Lubiprostone Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Lubiprostone Market Size 2017-2022 ($ Millions)
Figure 15. APAC Lubiprostone Market Size 2017-2022 ($ Millions)
Figure 16. Europe Lubiprostone Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Lubiprostone Market Size 2017-2022 ($ Millions)
Figure 18. Americas Lubiprostone Value Market Share by Country in 2021
Figure 19. Americas Lubiprostone Consumption Market Share by Type in 2021
Figure 20. Americas Lubiprostone Market Size Market Share by Application in 2021
Figure 21. United States Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Lubiprostone Market Size Market Share by Region in 2021
Figure 26. APAC Lubiprostone Market Size Market Share by Application in 2021
Figure 27. China Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Lubiprostone Market Size Market Share by Country in 2021
Figure 34. Europe Lubiprostone Market Size Market Share by Type in 2021
Figure 35. Europe Lubiprostone Market Size Market Share by Application in 2021
Figure 36. Germany Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Lubiprostone Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Lubiprostone Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Lubiprostone Market Size Market Share by Application in 2021
Figure 44. Egypt Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Lubiprostone Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 50. APAC Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 51. Europe Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 53. United States Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 54. Canada Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 57. China Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 58. Japan Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 59. Korea Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 61. India Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 62. Australia Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 63. Germany Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 64. France Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 65. UK Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 66. Italy Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 67. Russia Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 68. Spain Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 71. Israel Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Lubiprostone Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Lubiprostone Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...